Bank of America’s Natus Medical Inc NTUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-128,280
| Closed | -$4.2M | – | 8589 |
|
|
2022
Q2 | $4.2M | Sell |
128,280
-35,534
| -22% | -$1.12M | ﹤0.01% | 3586 |
|
|
2022
Q1 | $4.3M | Sell |
163,814
-2,983
| -2% | -$72.8K | ﹤0.01% | 3788 |
|
|
2021
Q4 | $3.96M | Sell |
166,797
-9,498
| -5% | -$234K | ﹤0.01% | 3891 |
|
|
2021
Q3 | $4.42M | Buy |
176,295
+38,654
| +28% | +$985K | ﹤0.01% | 3678 |
|
|
2021
Q2 | $3.58M | Sell |
137,641
-63,967
| -32% | -$1.74M | ﹤0.01% | 3829 |
|
|
2021
Q1 | $5.16M | Buy |
201,608
+68,616
| +52% | +$1.76M | ﹤0.01% | 3360 |
|
|
2020
Q4 | $2.67M | Sell |
132,992
-13,551
| -9% | -$265K | ﹤0.01% | 3696 |
|
|
2020
Q3 | $2.51M | Buy |
146,543
+29,553
| +25% | +$559K | ﹤0.01% | 3492 |
|
|
2020
Q2 | $2.55M | Sell |
116,990
-3,452
| -3% | -$79K | ﹤0.01% | 3414 |
|
|
2020
Q1 | $2.79M | Buy |
120,442
+323
| +0.3% | +$9.39K | ﹤0.01% | 3215 |
|
|
2019
Q4 | $3.96M | Sell |
120,119
-9,091
| -7% | -$291K | ﹤0.01% | 3448 |
|
|
2019
Q3 | $4.11M | Sell |
129,210
-4,232
| -3% | -$123K | ﹤0.01% | 3393 |
|
|
2019
Q2 | $3.43M | Sell |
133,442
-39,565
| -23% | -$1.01M | ﹤0.01% | 3582 |
|
|
2019
Q1 | $4.39M | Buy |
173,007
+8,631
| +5% | +$258K | ﹤0.01% | 3284 |
|
|
2018
Q4 | $5.59M | Sell |
164,376
-6,239
| -4% | -$203K | ﹤0.01% | 2873 |
|
|
2018
Q3 | $6.08M | Sell |
170,615
-111,825
| -40% | -$3.95M | ﹤0.01% | 3001 |
|
|
2018
Q2 | $9.74M | Buy |
282,440
+28,775
| +11% | +$1.01M | ﹤0.01% | 2503 |
|
|
2018
Q1 | $8.54M | Buy |
253,665
+92,956
| +58% | +$2.94M | ﹤0.01% | 2555 |
|
|
2017
Q4 | $6.14M | Sell |
160,709
-80,120
| -33% | -$3.2M | ﹤0.01% | 2929 |
|
|
2017
Q3 | $9.03M | Buy |
240,829
+94,009
| +64% | +$3.32M | ﹤0.01% | 2601 |
|
|
2017
Q2 | $5.48M | Sell |
146,820
-61,425
| -29% | -$2.22M | ﹤0.01% | 2947 |
|
|
2017
Q1 | $8.17M | Sell |
208,245
-73,912
| -26% | -$2.77M | ﹤0.01% | 2585 |
|
|
2016
Q4 | $9.82M | Buy |
282,157
+10,789
| +4% | +$424K | ﹤0.01% | 2341 |
|
|
2016
Q3 | $10.7M | Sell |
271,368
-2,474
| -0.9% | -$98.7K | ﹤0.01% | 2182 |
|
|
2016
Q2 | $10.4M | Sell |
273,842
-40,588
| -13% | -$1.36M | ﹤0.01% | 2161 |
|
|
2016
Q1 | $12.1M | Buy |
314,430
+45,254
| +17% | +$1.69M | ﹤0.01% | 1985 |
|
|
2015
Q4 | $12.9M | Sell |
269,176
-6,382
| -2% | -$295K | ﹤0.01% | 2026 |
|
|
2015
Q3 | $10.9M | Buy |
275,558
+230,393
| +510% | +$9.79M | ﹤0.01% | 2151 |
|
|
2015
Q2 | $1.92M | Buy |
45,165
+32,751
| +264% | +$1.31M | ﹤0.01% | 3509 |
|
|
2015
Q1 | $490K | Sell |
12,414
-14,980
| -55% | -$552K | ﹤0.01% | 4339 |
|
|
2014
Q4 | $987K | Buy |
27,394
+14,932
| +120% | +$502K | ﹤0.01% | 4051 |
|
|
2014
Q3 | $367K | Buy |
12,462
+1,930
| +18% | +$53.3K | ﹤0.01% | 4859 |
|
|
2014
Q2 | $265K | Sell |
10,532
-8,799
| -46% | -$218K | ﹤0.01% | 5280 |
|
|
2014
Q1 | $499K | Sell |
19,331
-16,396
| -46% | -$413K | ﹤0.01% | 4590 |
|
|
2013
Q4 | $804K | Buy |
35,727
+17,867
| +100% | +$345K | ﹤0.01% | 4313 |
|
|
2013
Q3 | $253K | Sell |
17,860
-18,865
| -51% | -$252K | ﹤0.01% | 5250 |
|
|
2013
Q2 | $501K | Buy |
+36,725
| New | +$500K | ﹤0.01% | 4747 |
|
Other funds holding NTUS
Bank of America's NTUS Position: Q3 2022 in Review
Bank of America sold out of Natus Medical Inc (NTUS) in Q3 2022, closing a stake of 128,280 shares — an estimated $4.2M sold.
Bank of America first reported a position in NTUS in Q2 2013 and held it in 37 quarters. The position peaked at $12.9M in Q4 2015. 1 fund tracked by Wall St. Rank holds NTUS as of Q3 2022.
- Bank of America reported no remaining Natus Medical Inc position as of Q3 2022 after selling out during the quarter.
- Bank of America sold 128,280 Natus Medical Inc shares in Q3 2022, an estimated $4.2M.
- Bank of America first reported a position in Natus Medical Inc in Q2 2013 and held it in 37 quarters.
- Bank of America's Natus Medical Inc position peaked at $12.9M in Q4 2015.
- 1 fund tracked by Wall St. Rank held Natus Medical Inc as of Q3 2022.
Based on Bank of America's 13F filing for Q3 2022, filed 14 Nov 2022.